Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DRH | PPTA |
|---|---|---|
| Price | $12.42 | $20.33 |
| Change today | ▼ 1.19% | ▼ 0.25% |
| Market cap | $2.54B | $2.54B |
| Return, 3 months | +6.6% | +1.7% |
| Return, year to date | +42.2% | -16.0% |
| Return, 1 year | +64.3% | -13.8% |
| P/E (TTM) | 17.3 | -9.9 |
| P/B | 1.7 | 3.5 |
| P/E percentile vs own 5y | 21st | 54th |
| Dividend yield | 2.74% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +11.0% | +89.4% |
| Analyst buy share | 29% | 100% |
| RSI (14) | 54 | 33 |
| 30-day volatility | 19.8% | 50.3% |
| Max drawdown, 1 year | -10.8% | -54.6% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
